Cu Chemie Uetikon GmbH

Activities: Manufacturing Ingredients Research & Development

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Pharma innovation - the big issues

<p>With only four months to go before CPhI kicks off in Madrid, and less than two months before the CPhI Innovation Awards entry deadline on31 July, Innovation Award judges Hendrik Baumann (CU Chemie Uetikon) and Hans-Leonhard Ohrem (Merck) discuss key issues facing pharmaceutical innovation</p>

Widened entry for CPhI Innovation Awards

<p>The sixth CPhI Innovation Awards, organised by UBM International Media - formerly CMPi - are to be judged and presented in Madrid on the first day of the 2009 CPhI Worldwide, Tuesday 13 October. </p>
Ingredients

EU to lift antidumping duties on exports of tartaric acid from China

<p>The European Commission has proposed lifting a definitive antidumping duty of 34.9% imposed in 2006 on imports into the EU of tartaric acid from China, for a special variant used in the pharmaceutical industry. </p>
Ingredients

Avecia tops the poll in the CPhI Innovation Awards 2007

<p>In a lively ceremony preceded by Brazilian dancers, Avecia Biologics was presented with the Gold Award in the CPhI Innovation Awards 2007. </p>
Subscribe now